Leading Innovation in the Life Sciences
New York Bio Connect aims to simplify and amplify the state and city’s life sciences ecosystem, organizing opportunities from Manhattan to Buffalo to position students, entrepreneurs, investors, policy makers, and established industry leaders for success.
Funding
Investing in innovation
Careers
Your future starts here
The Latest
Health Tech Among Winners of 2026 New York State Commercialization Competition
Empire State Development (ESD) gave $430,000 to four early-stage New York companies in the 10th annual New York State Commercialization Competition. FuzeHub hosted the competition at the New York State Innovation Summit. Nine entrepreneurs from across the state competed for the four awards. The money comes from ESD’s NYSTAR division and the FuzeHub Jeff Lawrence…
Building the Connections That Move New York Forward: Takeaways from NewYorkBIO’s Innovation Summit
How does New York translate its assets in talent, capital, and infrastructure into innovative results? That question ran through every session of NewYorkBIO’s Innovation Summit on September 30, 2026. Panels with representation spanning the ecosystem discussed the following themes addressing the state of translation. Opportunities in research translation and capital sourcing Seema Kumar, CEO of Cure […]
New Report Highlights New York Leading Nation In Life Sciences Job Growth, Research, Funding & Innovation
New York ranks among the top three states in six national measures of bioscience research, investment and production, according to the 2026 U.S. Bioscience Economy report. The biennial report, produced by TEConomy Partners with BIO and the Council of State Bioscience Associations (CSBA), covers 2021 through 2025. The state’s bioscience industry supported 118,906 jobs across…
ARPA-H Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Are you developing a team for the ARPA-H SURPASS program? New York State is seeking to identify New York-anchored SURPASS teams, understand capability and partner gaps, and help connect complementary clinical, industry, statistical, AI/modeling, regulatory, and operational partners. Teams seeking State coordination or support should review the NYS Statement of Principles and submit a Notice of Intent by 5:00 PM ET on […]
NIH Research, Evaluation, and Commercialization Hubs (REACH) (SBO Clinical Trial Optional
Are you submitting an application to the NIH REACH (Research Evaluation and Commercialization Hubs) program? New York State is interested in supporting competitive New York-led applications that meet NIH requirements and strengthen the State’s biomedical innovation and commercialization ecosystem. Institutions seeking New York State support should review the NYS Statement of Principles and submit a completed Notice of Intent by October 23, 2026. The […]
LIFE SCIENCES IN NEW YORK
Where science and opportunity come together
New York’s life science sector has attracted unprecedented investment, expanded research clusters across the state, and nurtured the growth of early-stage companies.
#2
NATIONAL R&D SPEND
100,000+
LIFE SCIENCES JOBS
25%
CLINICAL TRIALS IN THE U.S.